Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.30 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.30 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.30 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26468762 | 0.94 | ALOX5 (0.35) | ALOX5KDM4EMEN1ALDH1A1LMNA | |
| SCHEMBL26468807 | 0.87 | — | — | |
| SCHEMBL26468829 | 0.87 | ALOX5 (0.32) | ALOX5KDM4EMEN1ALDH1A1LMNA | |
| SCHEMBL26468824 | 0.85 | KDM4E (0.31) | ALOX5KDM4EMEN1ALDH1A1POLB | |
| SCHEMBL26468828 | 0.83 | BACE1 (0.34) | KDM4EMEN1ALDH1A1LMNAPOLB | |
| SCHEMBL26468516 | 0.82 | ALOX5 (0.33) | ALOX5KDM4EALDH1A1MAPTAVPR2 | |
| SCHEMBL26468599 | 0.82 | KDM4E (0.33) | ALOX5KDM4EMEN1ALDH1A1LMNA | |
| SCHEMBL26468822 | 0.81 | KDM4E (0.31) | ALOX5KDM4EMEN1ALDH1A1LMNA | |
| SCHEMBL26468809 | 0.81 | CCR1 (0.33) | KDM4EMEN1ALDH1A1LMNAPOLB | |
| SCHEMBL21120229 | 0.78 | ALOX5 (0.38) | ALOX5KDM4EMEN1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230137213-A1 | NOVEL PHENANTHROLINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD. (KR) | 2023-05-04 | — | — | US | disclosed |
| US-20230137213-A1 | NOVEL PHENANTHROLINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD. (KR) | 2023-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230137213-A1 | NOVEL PHENANTHROLINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | PPOX, PAH, CRY2 | ALOX5 1332/4885KDM4E 907/4885MEN1 1382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.